Titre : Poumon hyperclair

Poumon hyperclair : Questions médicales fréquentes

Termes MeSH sélectionnés :

Time and Motion Studies

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer un poumon hyperclair ?

Le diagnostic se fait par radiographie thoracique et éventuellement par scanner.
Radiographie Scanner Poumon hyperclair
#2

Quels examens complémentaires sont utiles ?

Des tests fonctionnels respiratoires et une tomodensitométrie peuvent être réalisés.
Tomodensitométrie Tests fonctionnels respiratoires
#3

Quels signes radiologiques indiquent un poumon hyperclair ?

Une diminution de la densité pulmonaire et une augmentation de la transparence sont observées.
Densité pulmonaire Radiologie
#4

Le poumon hyperclair est-il toujours pathologique ?

Non, il peut être physiologique chez les jeunes enfants ou en cas d'hyperinflation.
Hyperinflation Physiologique
#5

Quel rôle joue l'anamnèse dans le diagnostic ?

L'anamnèse aide à identifier des antécédents de maladies respiratoires ou d'exposition.
Anamnèse Maladies respiratoires

Symptômes 5

#1

Quels symptômes sont associés au poumon hyperclair ?

Les symptômes peuvent inclure une dyspnée, une toux ou des douleurs thoraciques.
Dyspnée Toux Douleurs thoraciques
#2

Le poumon hyperclair provoque-t-il des douleurs ?

Pas directement, mais des douleurs peuvent survenir en raison de maladies sous-jacentes.
Douleurs thoraciques Maladies sous-jacentes
#3

Y a-t-il des symptômes spécifiques chez les enfants ?

Les enfants peuvent présenter des symptômes respiratoires aigus ou chroniques.
Enfants Symptômes respiratoires
#4

Comment la toux se manifeste-t-elle ?

La toux peut être sèche ou productive, selon la cause sous-jacente du poumon hyperclair.
Toux Causes sous-jacentes
#5

Le poumon hyperclair est-il asymptomatique ?

Oui, il peut être asymptomatique, surtout dans les cas d'hyperinflation bénigne.
Asymptomatique Hyperinflation

Prévention 5

#1

Comment prévenir le poumon hyperclair ?

Éviter le tabagisme et les polluants environnementaux peut réduire les risques.
Prévention Tabagisme Polluants environnementaux
#2

Y a-t-il des vaccinations recommandées ?

Oui, la vaccination contre la grippe et le pneumocoque est conseillée.
Vaccination Grippe Pneumocoque
#3

Comment surveiller la santé pulmonaire ?

Des examens réguliers et des tests de fonction pulmonaire sont recommandés.
Surveillance Tests de fonction pulmonaire
#4

Les exercices respiratoires aident-ils ?

Oui, ils peuvent améliorer la capacité pulmonaire et la santé respiratoire.
Exercices respiratoires Capacité pulmonaire
#5

Quelles habitudes de vie adopter ?

Adopter une alimentation équilibrée et faire de l'exercice régulièrement est bénéfique.
Habitudes de vie Alimentation équilibrée

Traitements 5

#1

Quel traitement pour un poumon hyperclair ?

Le traitement dépend de la cause sous-jacente, comme des bronchodilatateurs pour l'asthme.
Traitement Bronchodilatateurs Asthme
#2

Les antibiotiques sont-ils nécessaires ?

Ils ne sont nécessaires que si une infection bactérienne est suspectée.
Antibiotiques Infection bactérienne
#3

Quand envisager une intervention chirurgicale ?

Une chirurgie peut être envisagée en cas de complications graves comme un pneumothorax.
Chirurgie Pneumothorax
#4

Les corticostéroïdes sont-ils efficaces ?

Oui, ils peuvent être utilisés pour réduire l'inflammation dans certaines conditions.
Corticostéroïdes Inflammation
#5

Comment gérer les symptômes respiratoires ?

Des bronchodilatateurs et des thérapies respiratoires peuvent aider à soulager les symptômes.
Thérapies respiratoires Bronchodilatateurs

Complications 5

#1

Quelles complications peuvent survenir ?

Des complications comme le pneumothorax ou l'insuffisance respiratoire peuvent se produire.
Complications Pneumothorax Insuffisance respiratoire
#2

Le poumon hyperclair peut-il entraîner des infections ?

Oui, une hyperinflation peut prédisposer à des infections pulmonaires.
Infections pulmonaires Hyperinflation
#3

Comment gérer les complications ?

La gestion dépend de la complication, nécessitant parfois une hospitalisation.
Gestion Hospitalisation
#4

Le poumon hyperclair est-il réversible ?

Cela dépend de la cause; certaines conditions peuvent être réversibles avec un traitement.
Réversibilité Conditions
#5

Quels sont les risques à long terme ?

Les risques incluent une détérioration de la fonction pulmonaire et des complications chroniques.
Risques à long terme Fonction pulmonaire

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque ?

Le tabagisme, l'exposition à des polluants et des antécédents familiaux de maladies respiratoires.
Facteurs de risque Tabagisme Polluants
#2

L'âge influence-t-il le risque ?

Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées.
Âge Fumeurs Exposition
#3

Les maladies pulmonaires prédisposent-elles ?

Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de poumon hyperclair.
Asthme BPCO Maladies pulmonaires
#4

Le mode de vie joue-t-il un rôle ?

Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque.
Mode de vie Sédentarité Alimentation
#5

Les allergies sont-elles un facteur ?

Certaines allergies respiratoires peuvent contribuer à des problèmes pulmonaires, y compris l'hyperclarté.
Allergies Problèmes pulmonaires
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Poumon hyperclair : Questions médicales les plus fréquentes", "headline": "Poumon hyperclair : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Poumon hyperclair : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Poumon hyperclair" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies pulmonaires", "url": "https://questionsmedicales.fr/mesh/D008171", "about": { "@type": "MedicalCondition", "name": "Maladies pulmonaires", "code": { "@type": "MedicalCode", "code": "D008171", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.381" } } }, "about": { "@type": "MedicalCondition", "name": "Poumon hyperclair", "alternateName": "Lung, Hyperlucent", "code": { "@type": "MedicalCode", "code": "D019568", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hiromichi Niikawa", "url": "https://questionsmedicales.fr/author/Hiromichi%20Niikawa", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan." } }, { "@type": "Person", "name": "Kenneth R McCurry", "url": "https://questionsmedicales.fr/author/Kenneth%20R%20McCurry", "affiliation": { "@type": "Organization", "name": "Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA." } }, { "@type": "Person", "name": "Joshua M Diamond", "url": "https://questionsmedicales.fr/author/Joshua%20M%20Diamond", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania." } }, { "@type": "Person", "name": "Hisashi Oishi", "url": "https://questionsmedicales.fr/author/Hisashi%20Oishi", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp." } }, { "@type": "Person", "name": "Takashi Hirama", "url": "https://questionsmedicales.fr/author/Takashi%20Hirama", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Analysis of home care nurses' workload: A time-motion study.", "datePublished": "2023-04-16", "url": "https://questionsmedicales.fr/article/37061940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01621424.2023.2202149" } }, { "@type": "ScholarlyArticle", "name": "The Time, Places, and Activities of Nurses in a Psychiatric Inpatient Context - A Time and Motion Study with a Time-geographic Perspective.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37126738", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01612840.2023.2194990" } }, { "@type": "ScholarlyArticle", "name": "Activities of the oral health teams in primary health care: a time-motion study.", "datePublished": "2024-05-10", "url": "https://questionsmedicales.fr/article/38730416", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-024-11053-5" } }, { "@type": "ScholarlyArticle", "name": "Understanding the workflow of nurses in acute and subacute medical wards: A time and motion study.", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37489643", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocn.16835" } }, { "@type": "ScholarlyArticle", "name": "A time motion study of manual versus artificial intelligence methods for wound assessment.", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35901189", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271742" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Maladies pulmonaires", "item": "https://questionsmedicales.fr/mesh/D008171" }, { "@type": "ListItem", "position": 4, "name": "Poumon hyperclair", "item": "https://questionsmedicales.fr/mesh/D019568" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Poumon hyperclair - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Poumon hyperclair", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Poumon hyperclair", "description": "Comment diagnostiquer un poumon hyperclair ?\nQuels examens complémentaires sont utiles ?\nQuels signes radiologiques indiquent un poumon hyperclair ?\nLe poumon hyperclair est-il toujours pathologique ?\nQuel rôle joue l'anamnèse dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Time+and+Motion+Studies#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Poumon hyperclair", "description": "Quels symptômes sont associés au poumon hyperclair ?\nLe poumon hyperclair provoque-t-il des douleurs ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nComment la toux se manifeste-t-elle ?\nLe poumon hyperclair est-il asymptomatique ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Time+and+Motion+Studies#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Poumon hyperclair", "description": "Comment prévenir le poumon hyperclair ?\nY a-t-il des vaccinations recommandées ?\nComment surveiller la santé pulmonaire ?\nLes exercices respiratoires aident-ils ?\nQuelles habitudes de vie adopter ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Time+and+Motion+Studies#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Poumon hyperclair", "description": "Quel traitement pour un poumon hyperclair ?\nLes antibiotiques sont-ils nécessaires ?\nQuand envisager une intervention chirurgicale ?\nLes corticostéroïdes sont-ils efficaces ?\nComment gérer les symptômes respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Time+and+Motion+Studies#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Poumon hyperclair", "description": "Quelles complications peuvent survenir ?\nLe poumon hyperclair peut-il entraîner des infections ?\nComment gérer les complications ?\nLe poumon hyperclair est-il réversible ?\nQuels sont les risques à long terme ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Time+and+Motion+Studies#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Poumon hyperclair", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes maladies pulmonaires prédisposent-elles ?\nLe mode de vie joue-t-il un rôle ?\nLes allergies sont-elles un facteur ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Time+and+Motion+Studies#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un poumon hyperclair ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par radiographie thoracique et éventuellement par scanner." } }, { "@type": "Question", "name": "Quels examens complémentaires sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests fonctionnels respiratoires et une tomodensitométrie peuvent être réalisés." } }, { "@type": "Question", "name": "Quels signes radiologiques indiquent un poumon hyperclair ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution de la densité pulmonaire et une augmentation de la transparence sont observées." } }, { "@type": "Question", "name": "Le poumon hyperclair est-il toujours pathologique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, il peut être physiologique chez les jeunes enfants ou en cas d'hyperinflation." } }, { "@type": "Question", "name": "Quel rôle joue l'anamnèse dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'anamnèse aide à identifier des antécédents de maladies respiratoires ou d'exposition." } }, { "@type": "Question", "name": "Quels symptômes sont associés au poumon hyperclair ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure une dyspnée, une toux ou des douleurs thoraciques." } }, { "@type": "Question", "name": "Le poumon hyperclair provoque-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Pas directement, mais des douleurs peuvent survenir en raison de maladies sous-jacentes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes respiratoires aigus ou chroniques." } }, { "@type": "Question", "name": "Comment la toux se manifeste-t-elle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La toux peut être sèche ou productive, selon la cause sous-jacente du poumon hyperclair." } }, { "@type": "Question", "name": "Le poumon hyperclair est-il asymptomatique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être asymptomatique, surtout dans les cas d'hyperinflation bénigne." } }, { "@type": "Question", "name": "Comment prévenir le poumon hyperclair ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et les polluants environnementaux peut réduire les risques." } }, { "@type": "Question", "name": "Y a-t-il des vaccinations recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre la grippe et le pneumocoque est conseillée." } }, { "@type": "Question", "name": "Comment surveiller la santé pulmonaire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests de fonction pulmonaire sont recommandés." } }, { "@type": "Question", "name": "Les exercices respiratoires aident-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent améliorer la capacité pulmonaire et la santé respiratoire." } }, { "@type": "Question", "name": "Quelles habitudes de vie adopter ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Adopter une alimentation équilibrée et faire de l'exercice régulièrement est bénéfique." } }, { "@type": "Question", "name": "Quel traitement pour un poumon hyperclair ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, comme des bronchodilatateurs pour l'asthme." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne sont nécessaires que si une infection bactérienne est suspectée." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie peut être envisagée en cas de complications graves comme un pneumothorax." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être utilisés pour réduire l'inflammation dans certaines conditions." } }, { "@type": "Question", "name": "Comment gérer les symptômes respiratoires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des bronchodilatateurs et des thérapies respiratoires peuvent aider à soulager les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme le pneumothorax ou l'insuffisance respiratoire peuvent se produire." } }, { "@type": "Question", "name": "Le poumon hyperclair peut-il entraîner des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hyperinflation peut prédisposer à des infections pulmonaires." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion dépend de la complication, nécessitant parfois une hospitalisation." } }, { "@type": "Question", "name": "Le poumon hyperclair est-il réversible ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la cause; certaines conditions peuvent être réversibles avec un traitement." } }, { "@type": "Question", "name": "Quels sont les risques à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent une détérioration de la fonction pulmonaire et des complications chroniques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des polluants et des antécédents familiaux de maladies respiratoires." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées." } }, { "@type": "Question", "name": "Les maladies pulmonaires prédisposent-elles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de poumon hyperclair." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les allergies sont-elles un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines allergies respiratoires peuvent contribuer à des problèmes pulmonaires, y compris l'hyperclarté." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 13/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Hiromichi Niikawa

4 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.
Publications dans "Poumon hyperclair" :

Kenneth R McCurry

3 publications dans cette catégorie

Affiliations :
  • Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :

Joshua M Diamond

2 publications dans cette catégorie

Affiliations :
  • Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Poumon hyperclair" :

Hisashi Oishi

2 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp.

Takashi Hirama

2 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.

Hirotsugu Notsuda

2 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.

Yoshinori Okada

2 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan.

Daisuke Nakajima

2 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. daink@kuhp.kyoto-u.ac.jp.
Publications dans "Poumon hyperclair" :

Hiroshi Date

2 publications dans cette catégorie

Affiliations :
  • Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Publications dans "Poumon hyperclair" :

Toshihiro Okamoto

2 publications dans cette catégorie

Affiliations :
  • Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Transplant Center, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :

Kamal S Ayyat

2 publications dans cette catégorie

Affiliations :
  • Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Cardiothoracic Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Publications dans "Poumon hyperclair" :

Yoshifumi Itoda

2 publications dans cette catégorie

Affiliations :
  • Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
Publications dans "Poumon hyperclair" :

Tiago N Machuca

2 publications dans cette catégorie

Affiliations :
  • Department of Surgery, University of Florida, Gainesville, Florida, USA.
Publications dans "Poumon hyperclair" :

Mauricio Pipkin

2 publications dans cette catégorie

Affiliations :
  • Department of Surgery, University of Florida Health, Gainesville, Florida, USA.
Publications dans "Poumon hyperclair" :

Juan J Pérez Guerrero

1 publication dans cette catégorie

Affiliations :
  • Hospital Universitario Puerta del Mar, Cádiz, España. jj_perezguerrero@hotmail.com.
Publications dans "Poumon hyperclair" :

Carlos A Sánchez Salguero

1 publication dans cette catégorie

Affiliations :
  • Hospital Universitario Puerta del Mar, Cádiz, España.
Publications dans "Poumon hyperclair" :

Sujith V Cherian

1 publication dans cette catégorie

Affiliations :
  • Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas Health - McGovern Medical School, Houston, TX.
Publications dans "Poumon hyperclair" :

Francis Girvin

1 publication dans cette catégorie

Affiliations :
  • Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.
Publications dans "Poumon hyperclair" :

David P Naidich

1 publication dans cette catégorie

Affiliations :
  • Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.
Publications dans "Poumon hyperclair" :

Stephen Machnicki

1 publication dans cette catégorie

Affiliations :
  • Department of Radiology, Lenox Hill Hospital, New York, NY.
Publications dans "Poumon hyperclair" :

Sources (10000 au total)

Activities of the oral health teams in primary health care: a time-motion study.

Efficient planning of the oral health workforce in Primary Health Care (PHC) is paramount to ensure equitable community access to services. This requires a meticulous examination of the population's n... Calculate the average time parameters for the activities carried out by the oral health team in primary health care.... This is a descriptive observational study using the time-motion method carried out in five Primary Health Care Units in the city of São Paulo, SP, Brazil. Direct and continuous observation of oral hea... A total of 696.05 h of observation were conducted with 12 Dentists, three Oral Health Assistants, and five Oral Health Technicians. The Dentists' main activity was consultation with an average duratio... The study establishes time standards for the activities performed by the dental care team and provides support for the application of workforce planning methods that allow for review and optimization ...

Understanding the workflow of nurses in acute and subacute medical wards: A time and motion study.

The aim of this study was to determine how much time nurses spend on direct and indirect patient care in acute and subacute hospital settings.... Quantifying direct and indirect nursing care provided during inpatient stay is vital to optimise the quality of care and manage resources.... Time and motion cross-sectional observational study and reported the study according to the STROBE guideline.... Nurses working in an acute or subacute medical wards of a single health service participated. Nurses were observed twice for 2 h on the same day with an observer break in between sessions. Real-time t... Twenty-one nurses (acute n = 12, subacute n = 9) were observed during shifts between 7 AM and 9 PM in May-July 2021. A total of 7240 tasks were recorded. Nurses spent a third of their time on direct p... Time spent on tasks was similar regardless of the setting and was consistent with previous research. We found differences in the distribution of tasks throughout the day between settings, which could ...

A time motion study of manual versus artificial intelligence methods for wound assessment.

This time-motion study explored the amount of time clinicians spent on wound assessments in a real-world environment using wound assessment digital application utilizing Artificial Intelligence (AI) v... Clinicians practicing at Valley Wound Center who agreed to join the study were asked to record the time needed to complete wound assessment activities for patients with active wounds referred for a ro... A total of 91 patients with 115 wounds were assessed. The average time to capture and access wound image with the AI digital tool was significantly faster than a standard digital camera with an averag... Using the digital assessment tool saved significant time for clinicians in assessing wounds. It also successfully captured quality wound images at the first attempt....

Impact of school-based malaria intervention on primary school teachers' time in Malawi: evidence from a time and motion study.

School-based health (SBH) programmes that are contingent on primary school teachers are options to increase access to malaria treatment among learners. However, perceptions that provision of healthcar... A time and motion study was conducted in 10 primary schools in rural Malawi. Teachers who had been trained to diagnose and treat uncomplicated malaria were continuously observed in real time during sc... Seventy-four teachers, trained to use LTK, were observed. Their mean age and years of teaching experience were 34.7 and 8.7, respectively. Overall, 739.8 h of teacher observations took place. The aver... School-based health (SBH) programmes are not detrimental to teaching activities. Teachers manage their time to ensure additional time required for SBH services is not at the expense of teaching duties...

Assessing community health workers' time allocation for a cervical cancer screening and treatment intervention in Malawi: a time and motion study.

Community health workers (CHWs) are essential field-based personnel and increasingly used to deliver priority interventions to achieve universal health coverage. Existing literature allude to the pote... A time and motion study was conducted in 7 health facilities in Malawi. Data was collected at baseline between October-July 2019, and 12 months after CCSPT implementation between July and August 2021.... Thirty-seven (n = 37) CHWs were observed. Their mean age and years of experience were 42 and 17, respectively. Overall, CHWs were observed for 323 hours (inter quartile range: 2.8-5.5). Compared with ... Introduction of CCSPT was not very detrimental to pre-existing community services. CHWs managed their time ensuring additional efforts required for CCSPT were not at the expense of essential activitie...

Determinants of received care time among Finnish home care clients and assisted living facility residents: a time-motion study.

Ageing populations and care workforce shortages across Europe are causing challenges for care services for older people. Therefore, it is paramount that limited care resources are allocated optimally,... Cross-sectional observational study design with data from time and motion study, registers, and surveys was used. In total, 1477 home care clients and 1538 residents from assisted living facilities wi... Physical functioning was the strongest predictor of received care time in both care settings. In home care, greater pain, more unstable health, and higher team autonomy were associated with increased ... Physical functioning was the main driver of received care time. Interventions that maintain or improve physical functioning can help restrain the growing need of care resources, although it is importa...

Time-motion analysis of taekwondo matches in the Tokyo 2020 Olympic Games.

The aim of the present study was to determine the time-motion structure of high-level taekwondo matches during the Tokyo 2020 Olympic Games in relation to sex, match outcome, weight category and match... Overall, 7007 actions were recorded during the analysis of 134 performances (67 rounds of 24 matches: four rounds of 16, eight quarterfinals, eight semifinals and four finals) in male and female flywe... The AT/ST ratio was ~1:1.5. Male athletes performed significantly longer (P<0.001) sum PT than female athletes. Flyweight athletes differed significantly from their heavyweight counterparts by having ... The rule changes and the implementation of the electronic score recording system had a major impact on the time-motion structure of combat by generating a considerably higher AT/ST ratio than in the p...

Electronic oral health surveillance system for Egyptian preschoolers using District Health Information System (DHIS2): design description and time motion study.

Early childhood caries (ECC) is a major global health issue affecting millions of children. Mitigating this problem requires up-to-date information from reliable surveillance systems. This enables evi... The DHIS2 Server was configured for the DHIS2 Tracker Android Capture App to allow individual-level data entry. The EOHSS indicators were selected in line with the WHO Action Plan 2030. Two modalities... The pilot team reported positive feedback on the structure of the EOHSS. Workflow adaptations were made to prioritize surveillance tasks by collecting data from caregivers before acquiring clinical da... The DHIS2 provides a feasible solution for developing electronic, oral health surveillance systems. The one-minute difference in data capture time in telemodality compared to face-to-face indicates th...